0001019056-18-000291.txt : 20180206
0001019056-18-000291.hdr.sgml : 20180206
20180206192332
ACCESSION NUMBER: 0001019056-18-000291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180203
FILED AS OF DATE: 20180206
DATE AS OF CHANGE: 20180206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stromatt Scott C
CENTRAL INDEX KEY: 0001679975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 18578960
MAIL ADDRESS:
STREET 1: 2401 4TH AVENUE
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
stromatt_4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-02-03
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001679975
Stromatt Scott C
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
0
1
0
0
Chief Medical Officer and SVP
Common Stock
2018-02-03
4
M
0
27381
A
174576
D
Restricted Stock Unit
2018-02-03
4
M
0
27381
0
D
Common Stock
27381
46430
D
Each RSU converts into the Issuer's common stock on a one-for-one basis.
On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018.
/s/ Benjamin J. Stein, attorney-in-fact
2018-02-06